alprazolam and triazolam

alprazolam has been researched along with triazolam in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (32.14)	18.7374
1990's	25 (29.76)	18.2507
2000's	19 (22.62)	29.6817
2010's	11 (13.10)	24.3611
2020's	2 (2.38)	2.80

Authors

Authors	Studies
Gall, M; Hester, JB; Lahti, RA; Rudzik, AD	1
Chidester, C; Duchamp, DJ; Gall, M; Lahti, RA; Rudzik, AD; Scahill, T	1
Collins, RJ; Gall, M; Kamdar, BV	1
Hester, JB; Von Voigtlander, P	1
Carroll, ML; Johnson, BD; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Trova, MP; Wissner, A	1
Carroll, ML; Green, KE; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Wissner, A; Wrenn, S	1
Bock, MG; Chang, RS; DiPardo, RM; Evans, BE; Freidinger, RM; Lotti, VJ; Rittle, KE; Veber, DF	1
Fujishita, T; Hirai, K; Hirose, K; Ishiba, T; Matsutani, S; Sugimoto, H; Tsukinoki, Y	1
Carroll, ML; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Trova, MP; Wissner, A	1
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Bracher, F; Fedorov, O; Filippakopoulos, P; Keller, M; Knapp, S; Morgenstern, O; Picaud, S; Wrobel, M	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Adam, K; Oswald, I	2
Loeffler, PM	1
Platt, D; Rieck, W	1
Beck, O; Borg, S; Hjemdahl, P; Lafolie, P; Odelius, G; Wirbing, P	1
Franklin, SR; Tang, AH	1
Ellinwood, EH; Gupta, SK; Heatherly, DG; Nikaido, AM	1
Krsiak, M; Sulcova, A	1
Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Pieri, L; Schoch, P	1
Burkhart, KK; Kulig, KW	1
Covington, EC; Rapport, DJ	1
Jones, CE; Martinez, LA; Merritt, GJ; Wians, FH	1
Kozlowski, MR	1
Greenblatt, DJ; Lopez, F; Miller, LG; Paul, SM; Shader, RI	1
Clow, A; Glover, V; Sandler, M	1
Desager, JP; Harvengt, C; Hulhoven, R; Pourbaix, S; Smith, RB	1
Ellinwood, EH; Heatherly, DG; Nikaido, AM	1
Albeck, JH	1
Barnhill, JG; Deutsch, SI; Greenblatt, DJ; Miller, LG; Paul, SM; Shader, RI	1
Obata, T; Yamamura, HI	1
Metys, J; Sulcová, A	1
Patterson, WM	1
Cagen, LM; Chesney, CM; Pifer, DD	1
Casals-Stenzel, J	1
Cox, CP; Wood, KL	1
Divoll, M; Greenblatt, DJ; Moschitto, LJ; Shader, RI	1
Harris, DW; Sethy, VH	1
Abernethy, DR; Divoll, M; Greenblatt, DJ; Harmatz, JS; Moschitto, LJ; Shader, RI	1
Ator, NA; Brady, JV; Griffiths, RR; Lamb, RJ; Lukas, SE	1
Juhl, RP; Kroboth, PD; Phillips, JP; Smith, RB; Stoehr, GP; Wender, DB	1
Ehrlich, YH; Kornecki, E; Lenox, RH	1
Needleman, SB; Porvaznik, M	1
Andrenyak, DM; Huang, W; Moody, DE; Rollins, DE	1
Feuerstein, G; Friedman, E; Wang, HY; Yue, TL	1
Gardner, CR; Laskin, DL; Laskin, JD	1
Barbarito, EJ; Falk, JL; Lau, CE	1
Barbhaiya, R; Chaikin, PC; Folan, MM; Kroboth, PD; Lush, RM; Salazar, DE; Shukla, UA	1
Asahi, T; Kuribara, H	1
Kroboth, PD; McAuley, JW	1
Furukori, H; Hayashi, K; Kaneko, S; Nagasaki, T; Ohkubo, T; Otani, K; Sugawara, K; Tasaki, H; Yasui, N	1
Corbett, K; Counihan, M; Ehrenberg, BL; Greenblatt, DJ; Harmatz, JS; Harrel, LM; Shader, RI; Tobias, S; von Moltke, LL; Wright, CE	1
Daily, JP; Greenblatt, DJ; Harmatz, JS; Shader, RI; von Moltke, LL	1
Balian, JD; Flockhart, DA; Yuan, R	1
Bickel, WK; Smith, BJ	1
Gomez, TH; Meisch, RA; Roache, JD	1
Cantrell, VE; Eckstein, J; Hall, SD; Hamman, MA; Jones, DR; Ring, BJ; Ruterbories, K; Williams, JA; Wrighton, SA	1
Gu, JK; Sun, L; Xia, R; Zhong, DF	1
Kulkarni, SK; Kumar, A	1
Masica, AL; Mayo, G; Wilkinson, GR	1
Jiang, Z; Tan, J; Tao, G; Xing, L; Yao, L; Zhang, Q; Zhu, Y	1
Benet, LZ	1
Dickson, SJ; Irving, RC	1
Galetin, A; Hallifax, D; Houston, JB	1
Mandrioli, R; Mercolini, L; Raggi, MA	1
Hanioka, N; Kuze, J; Morisaki, K; Mutoh, T; Nakura, H; Narimatsu, S; Takenaka, T	1
Chronister, CW; Goldberger, BA; Merves, ML	1
Marin, SJ; McMillin, GA	1
Barter, ZE; Cubitt, HE; Howgate, EM; Rostami-Hodjegan, A; Yeo, KR	1
Arima, Y; Nagao, M; Namera, A; Shiraishi, H; Tajima, T; Torikoshi, A; Toubou, H	1
In, MK; Jeong, YD; Kim, JY; Kim, MK; Paeng, KJ; Suh, SI	1
Hasegawa, M; Tahara, H; Watanabe, M	1
Al-Otaibi, JS	1
Gui, L; Hu, Y; Jia, W; Lan, K; Liu, C; Miao, J; Wang, C; Wei, W; Wu, Q; Zeng, W	1

Reviews

7 review(s) available for alprazolam and triazolam

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Oral benzodiazepines and conscious sedation: a review. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1992, Volume: 50, Issue:9 Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam	1992
Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Clonazepam; Diazepam; Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam	1987
Progesterone: does it affect response to drug? Psychopharmacology bulletin, 1997, Volume: 33, Issue:2 Topics: Alprazolam; Contraceptives, Oral; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Progesterone; Receptors, GABA-A; Temazepam; Triazolam	1997
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Alprazolam; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; HIV Protease Inhibitors; Humans; Hypnotics and Sedatives; Metabolic Clearance Rate; Microsomes, Liver; Oxidoreductases, N-Demethylating; Ritonavir; Triazolam	1999
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. Journal of clinical pharmacology, 1999, Volume: 39, Issue:11 Topics: Alprazolam; Anti-Anxiety Agents; Data Collection; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Humans; Itraconazole; Ketoconazole; Midazolam; Triazolam	1999
Benzodiazepine metabolism: an analytical perspective. Current drug metabolism, 2008, Volume: 9, Issue:8 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam	2008

Trials

7 trial(s) available for alprazolam and triazolam

Article	Year
Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology, 1990, Volume: 100, Issue:1 Topics: Adult; Aged; Aging; Alprazolam; Anti-Anxiety Agents; Brain; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Psychomotor Performance; Triazolam	1990
The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. Annals of emergency medicine, 1990, Volume: 19, Issue:3 Topics: Adult; Alprazolam; Carbon Monoxide Poisoning; Clinical Trials as Topic; Coma; Double-Blind Method; Drug Overdose; Flumazenil; Humans; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Suicide, Attempted; Triazolam	1990
Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam. Psychopharmacology, 1983, Volume: 80, Issue:3 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Cimetidine; Drug Interactions; Female; Guanidines; Humans; Male; Metabolic Clearance Rate; Middle Aged; Triazolam	1983
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Male; Mental Recall; Metabolic Clearance Rate; Piperazines; Psychomotor Performance; Triazolam; Triazoles	1995
Relationship between single oral dose pharmacokinetics of alprazolam and triazolam. International clinical psychopharmacology, 1997, Volume: 12, Issue:3 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Area Under Curve; Chromatography, High Pressure Liquid; GABA Modulators; Half-Life; Humans; Male; Smoking; Triazolam	1997
Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences. Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:3 Topics: Administration, Oral; Adult; Alprazolam; Antifungal Agents; Area Under Curve; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Hypnotics and Sedatives; Ketoconazole; Male; Reference Values; Time Factors; Triazolam	1998
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam. Clinical pharmacology and therapeutics, 2004, Volume: 76, Issue:4 Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biological Availability; Cytochrome P-450 CYP3A; Female; Humans; Male; Midazolam; Oxidoreductases, N-Demethylating; Triazolam	2004

Other Studies

70 other study(ies) available for alprazolam and triazolam

Article	Year
Synthesis and pharmacology of novel anxiolytic agents derived from 2-[(dialkylamino)methyl-4H-triazol-4-yl] benzophenones and related heterocyclic benzophenones. Journal of medicinal chemistry, 1976, Volume: 19, Issue:8 Topics: Animals; Anti-Anxiety Agents; Benzophenones; Drug Synergism; Electroshock; Ethanol; Male; Mice; Nicotine; Pentylenetetrazole; Semicarbazides; Strychnine; Triazoles	1976
Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles. Journal of medicinal chemistry, 1978, Volume: 21, Issue:6 Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Crystallography; Hypnotics and Sedatives; Imidazoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Models, Molecular; Molecular Conformation; Muscle Relaxation; Nicotine; Pentylenetetrazole; Rats; Seizures; Semicarbazides; Triazoles	1978
Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines. Journal of medicinal chemistry, 1978, Volume: 21, Issue:12 Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Hydroxylation; Male; Methods; Mice; Oxidation-Reduction; Triazolam; Triazoles	1978
6-Aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines. Influence of 1-substitution on pharmacological activity. Journal of medicinal chemistry, 1979, Volume: 22, Issue:11 Topics: Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Body Temperature; Dextroamphetamine; Male; Mice; Motor Activity; Structure-Activity Relationship	1979
Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF. Journal of medicinal chemistry, 1992, Dec-25, Volume: 35, Issue:26 Topics: Amides; Animals; Female; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Urea	1992
Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor. Journal of medicinal chemistry, 1992, May-01, Volume: 35, Issue:9 Topics: Animals; Female; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Structure-Activity Relationship	1992
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines. Journal of medicinal chemistry, 1988, Volume: 31, Issue:1 Topics: Animals; Benzodiazepines; Brain; Cholecystokinin; Gastric Emptying; Gastric Mucosa; Guinea Pigs; Indicators and Reagents; Pancreas; Rats; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship; Triazoles	1988
Amino acid amide derivatives of 2-[3-(aminomethyl)-4H-1,2,4-triazol-4-yl]benzophenones, a novel class of annelated peptidoaminobenzophenones. Journal of medicinal chemistry, 1982, Volume: 25, Issue:12 Topics: Anesthesia; Animals; Anticonvulsants; Behavior, Animal; Benzophenones; Chemical Phenomena; Chemistry; Chlorprothixene; Drug Interactions; Hypnotics and Sedatives; Male; Mice; Motor Activity; Postural Balance; Thiopental	1982
Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring. Journal of medicinal chemistry, 1993, Mar-05, Volume: 36, Issue:5 Topics: Amides; Animals; Carbamates; Imides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rabbits; Structure-Activity Relationship	1993
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Molecular characteristics for solid-state limited solubility. Journal of medicinal chemistry, 2008, May-22, Volume: 51, Issue:10 Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. Bioorganic & medicinal chemistry, 2012, Mar-15, Volume: 20, Issue:6 Topics: Alprazolam; Benzazepines; Benzodiazepines; Cell Cycle Proteins; GABA Modulators; Humans; Midazolam; Models, Molecular; Nuclear Proteins; Protein Interaction Maps; Protein Structure, Tertiary; Transcription Factors	2012
Triazolam and platelet-aggregating factor. Lancet (London, England), 1992, Jan-18, Volume: 339, Issue:8786 Topics: Alprazolam; Blister; Humans; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Triazolam	1992
High-performance liquid chromatographic method for the determination of alprazolam in plasma using the column-switching technique. Journal of chromatography, 1992, Jul-24, Volume: 578, Issue:2 Topics: Aged; Alprazolam; Chromatography, High Pressure Liquid; Humans; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Triazolam	1992
Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Clinical chemistry, 1992, Volume: 38, Issue:2 Topics: Adult; Alprazolam; Benzodiazepines; Chlordiazepoxide; False Negative Reactions; Flunitrazepam; Fluorescence Polarization Immunoassay; Humans; Immunoenzyme Techniques; Lorazepam; Male; Middle Aged; Nitrazepam; Triazolam	1992
The discriminative stimulus effects of diazepam in rats at two training doses. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:3 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Carbolines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Male; Morphine; Pentobarbital; Pyrazoles; Pyridazines; Rats; Rats, Inbred Strains; Triazolam	1991
Possible mechanism for adverse reactions to triazolam. Lancet (London, England), 1991, Nov-02, Volume: 338, Issue:8775 Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam	1991
Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice. Psychopharmacology, 1990, Volume: 101, Issue:3 Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Clonazepam; Lorazepam; Male; Mice; Motor Activity; Nitrazepam; Oxazepam; Shyness; Structure-Activity Relationship; Triazolam	1990
Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028. European journal of pharmacology, 1990, Nov-06, Volume: 190, Issue:1-2 Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Drug Implants; Mice; Mice, Inbred DBA; Receptors, GABA-A; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam	1990
Motor phenomena in benzodiazepine withdrawal. Hospital & community psychiatry, 1989, Volume: 40, Issue:12 Topics: Aged; Alprazolam; Anti-Anxiety Agents; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Female; Humans; Muscle Rigidity; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Urinary Incontinence	1989
Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives. Clinical chemistry, 1989, Volume: 35, Issue:7 Topics: Alprazolam; Benzodiazepines; Benzophenones; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Immunoenzyme Techniques; Midazolam; Triazolam	1989
Inhibition of the binding and the behavioral effects of thyrotropin-releasing hormone (TRH) by the triazolobenzodiazepines. Pharmacology, biochemistry, and behavior, 1988, Volume: 30, Issue:1 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Estazolam; In Vitro Techniques; Mice; Pentobarbital; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone; Triazolam	1988
Low-dose alprazolam augments motor activity in mice. Pharmacology, biochemistry, and behavior, 1988, Volume: 30, Issue:2 Topics: Alprazolam; Animals; Clonazepam; Exploratory Behavior; Flumazenil; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A; Triazolam	1988
Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding. Journal of neurochemistry, 1985, Volume: 45, Issue:2 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Clonazepam; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Triazolam	1985
Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:8 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Cimetidine; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Time Factors; Triazolam	1985
Comparative pharmacodynamics of benzodiazepines. Psychopharmacology series, 1987, Volume: 3 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam	1987
Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam. Journal of neurochemistry, 1987, Volume: 49, Issue:5 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Brain; Cerebral Cortex; Estazolam; Flumazenil; Hippocampus; Hypothalamus; Kinetics; Male; Mice; Receptors, GABA-A; Triazolam	1987
Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by triazolobenzodiazepines. Life sciences, 1988, Volume: 42, Issue:6 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Biological Transport; Cell Membrane; Cerebral Cortex; Chlorides; Drug Interactions; gamma-Aminobutyric Acid; Male; Rats; Rats, Inbred Strains; Triazolam	1988
[Pharmacologic characteristics of new triazolobenzodiazepine derivatives, triazolam and alprazolam]. Ceskoslovenska farmacie, 1988, Volume: 37, Issue:10 Topics: Alprazolam; Animals; Behavior, Animal; Mice; Rats; Sleep; Triazolam	1988
Triazolam withdrawal. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:9 Topics: Alprazolam; Diazepam; Drug Tolerance; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam	1988
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. Biochemical and biophysical research communications, 1987, Apr-14, Volume: 144, Issue:1 Topics: Alprazolam; Binding, Competitive; Blood Platelets; Diazepam; Humans; In Vitro Techniques; Kinetics; Platelet Activating Factor; Platelet Aggregation; Triazolam	1987
Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 1987, Volume: 335, Issue:3 Topics: Alprazolam; Animals; Azepines; Blood Pressure; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Injections, Intravenous; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Respiration; Triazolam	1987
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. Thrombosis research, 1987, Aug-01, Volume: 47, Issue:3 Topics: Alprazolam; Animals; Blood Platelets; Furans; In Vitro Techniques; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thiazoles; Triazolam	1987
Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. Journal of chromatography, 1981, Sep-11, Volume: 225, Issue:1 Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Half-Life; Humans; Triazolam	1981
Determination of biological activity of alprazolam, triazolam and their metabolites. The Journal of pharmacy and pharmacology, 1982, Volume: 34, Issue:2 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Brain; Diazepam; Flunitrazepam; Kinetics; Male; Membranes; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, GABA-A; Triazolam	1982
Benzodiazepines: drug discrimination and physiological dependence. NIDA research monograph, 1984, Volume: 49 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Humans; Lorazepam; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam	1984
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:5 Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Lorazepam; Smoking; Temazepam; Triazolam	1984
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science (New York, N.Y.), 1984, Dec-21, Volume: 226, Issue:4681 Topics: Adenosine Diphosphate; Alprazolam; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Platelets; Calcimycin; Chromatography, Gel; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin; Triazolam	1984
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase. Forensic science international, 1995, May-09, Volume: 73, Issue:1 Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam	1995
Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood. Journal of analytical toxicology, 1993, Volume: 17, Issue:6 Topics: Alprazolam; Anti-Anxiety Agents; Cross Reactions; Humans; Immunoassay; Lorazepam; Nordazepam; Triazolam	1993
Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. Journal of neurochemistry, 1994, Volume: 63, Issue:5 Topics: Acetylcholine; Alprazolam; Animals; Brain; Cerebral Cortex; GTP-Binding Proteins; Hippocampus; Norepinephrine; Platelet Activating Factor; Potassium; Rats; Serotonin; Tetrodotoxin; Triazolam; Tritium	1994
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells. Journal of leukocyte biology, 1993, Volume: 53, Issue:2 Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil	1993
Tolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Drinking Behavior; Drug Tolerance; Male; Rats; Saline Solution, Hypertonic; Triazolam	1996
Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Alprazolam; Animals; Anti-Anxiety Agents; Conflict, Psychological; Diazepam; Male; Maze Learning; Memory; Mice; Triazolam	1997
Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo. Drug and alcohol dependence, 2001, Feb-01, Volume: 61, Issue:3 Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Caffeine; Discrimination, Psychological; Female; GABA Agonists; GABA Modulators; Humans; Male; Phosphodiesterase Inhibitors; Pyridines; Triazolam; Zolpidem	2001
Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys. Psychopharmacology, 2002, Volume: 161, Issue:1 Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Diazepam; Macaca mulatta; Male; Reinforcement, Psychology; Self Administration; Triazolam	2002
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:8 Topics: Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clarithromycin; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Diltiazem; Estradiol; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Midazolam; Nifedipine; Tamoxifen; Testosterone; Triazolam	2002
[Identification of estazolam, alprazolam and triazolam in human urine by LC/MSn]. Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:2 Topics: Alprazolam; Anti-Anxiety Agents; Chromatography, Liquid; Estazolam; Humans; Male; Spectrometry, Mass, Electrospray Ionization; Triazolam	2002
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators. Indian journal of experimental biology, 2004, Volume: 42, Issue:5 Topics: Alprazolam; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agonists; GABA Modulators; Hypnosis; Hypnotics and Sedatives; Male; Medicine, Ayurvedic; Melatonin; Mice; Plant Extracts; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Time Factors; Triazolam; Zolpidem	2004
[Determination of alpha-hydroxytrizolam and alpha hydroxyaplrazolam from urine by acetylation derivatization using gas chromatography electron capture detection]. Se pu = Chinese journal of chromatography, 2004, Volume: 22, Issue:6 Topics: Acetylation; Adult; Alprazolam; Chromatography, Gas; Humans; Sensitivity and Specificity; Triazolam	2004
There are no useful CYP3A probes that quantitatively predict the in vivo kinetics of other CYP3A substrates and no expectation that one will be found. Molecular interventions, 2005, Volume: 5, Issue:2 Topics: Alprazolam; Benzodiazepines; Biopharmaceutics; Chemistry, Pharmaceutical; Cytochrome P-450 CYP3A; Drug Design; Humans; Kinetics; Midazolam; Molecular Probes; Protein Binding; Solubility; Triazolam	2005
The detection of sedatives in hair and nail samples using tandem LC-MS-MS. Forensic science international, 2007, Feb-14, Volume: 166, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam	2007
Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines. Xenobiotica; the fate of foreign compounds in biological systems, 2008, Volume: 38, Issue:4 Topics: Alprazolam; Benzodiazepines; Cell Survival; Cells, Cultured; Cryopreservation; Cytochrome P-450 CYP3A; Diazepam; Flunitrazepam; Hepatocytes; Humans; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Substrate Specificity; Triazolam	2008
Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice. Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:11 Topics: Administration, Oral; Alprazolam; Animals; Benzodiazepines; Biological Availability; Catheterization; Intestinal Mucosa; Jugular Veins; Liver; Male; Mice; Mice, Inbred BALB C; Midazolam; Portal Vein; Rats; Rats, Sprague-Dawley; Triazolam	2009
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS). Methods in molecular biology (Clifton, N.J.), 2010, Volume: 603 Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam	2010
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium. Methods in molecular biology (Clifton, N.J.), 2010, Volume: 603 Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Clonazepam; Flurazepam; Humans; Infant, Newborn; Meconium; Nordazepam; Oxazepam; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazolam	2010
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model. Xenobiotica; the fate of foreign compounds in biological systems, 2011, Volume: 41, Issue:8 Topics: Alprazolam; Benzodiazepines; Cytochrome P-450 CYP3A; Humans; Kinetics; Liver; Metabolic Clearance Rate; Midazolam; Triazolam	2011
[Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine]. Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2014, Volume: 27, Issue:1 Topics: Alprazolam; Benzodiazepines; Biomarkers; Cross Reactions; Diazepam; Humans; Immunoassay; Nitrazepam; Reagent Kits, Diagnostic; Sensitivity and Specificity; Structure-Activity Relationship; Substance Abuse Detection; Triazolam	2014
Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry. Forensic science international, 2015, Volume: 257 Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Flurazepam; Forensic Toxicology; Humans; Hypnotics and Sedatives; Limit of Detection; Pyridines; Tandem Mass Spectrometry; Triazolam; Zolpidem	2015
A comparative study for detecting CYP3A induction by CYP3A probe drugs and endogenous markers in cynomolgus monkeys. Biopharmaceutics & drug disposition, 2019, Volume: 40, Issue:2 Topics: Alprazolam; Animals; Area Under Curve; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Hydrocortisone; Hydroxycholesterols; Macaca fascicularis; Male; Midazolam; Rifampin; Triazolam	2019
Detailed quantum mechanical studies on bioactive benzodiazepine derivatives and their adsorption over graphene sheets. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020, Jul-05, Volume: 235 Topics: Adsorption; Algorithms; Alprazolam; Benzodiazepines; Catalytic Domain; Chemistry, Pharmaceutical; Electrons; Estazolam; Graphite; Humans; Molecular Docking Simulation; Orexin Receptors; Quantum Theory; Relaxin; Serum Albumin, Human; Spectrophotometry; Triazolam	2020
Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs. Drug metabolism and disposition: the biological fate of chemicals, 2022, Volume: 50, Issue:6 Topics: Alprazolam; Animals; Benzodiazepines; Cytochrome P-450 CYP3A; Deoxycholic Acid; Dogs; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Midazolam; Protein Isoforms; Species Specificity; Steroids; Triazolam	2022